Bon Natural Life (BON) Peer Comparison

$1.22

$0.02 (1.50%)

As on 28-Sep-2026 16:00EDT

Market cap

$317 Mln

Revenue (TTM)

$37 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Market cap ($ Mln)	317	884	1	24
Revenue ($ Mln)	19	104	1	18
Net Profit ($ Mln)	-1.99	53.81	-5.68	-3.67
Net Margin (%)	15.45	51.58	-591.67	--
RoE (%)	-3.93	18.35	-49.04	-7.23
Price to Earnings	--	16.38	--	--
Price-To-Book	0.17	3.05	0.28	0.42

Cashflow
Ratios

Cashflow ($ Mln)

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Cash From Operating Activities	0.14	238.54	-1.84	-5.05
Cash Flow from Investing Activities	-10.00	-105.28	--	-0.34
Cash from Financing Activities	15.45	-3.25	4.41	9.73
Net Cash Inflow / Outflow	--	--	--	--

Ratios

Profitability Ratios

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
ROCE (%)	-3.29	35.44	-5.34	-6.62
ROE (%)	-3.93	44.85	-6.16	-7.23
ROA (%)	-2.71	25.22	-7.83	-5.35
EBIT Margin (%)	--	--	--	--
Net Margin (%)	-10.68	98.54	--	-20.56
Cash Profit Margin (%)	--	--	--	--

Growth Ratios

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Revenue Growth (%)	-0.22	0.67	--	-0.22
EBIT Growth (%)	--	--	--	--
Net Profit Growth (%)	-600.98	287.70	68.06	57.92
EPS Growth (%)	-20.16	2.74	0.98	0.27
Book Value Growth (%)	--	--	--	--

Valuation Ratios

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Price / Earnings	-0.33	9.37	-5.72	0.00
Price / Book Value	0.01	3.35	0.34	0.00
Dividend Yield (%)	--	--	--	--
EV/EBITDA	-116.08	5.49	-4.28	8.32
Market Cap ($ Cr)	--	--	--	--

Solvency Ratios

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Debt to Equity	0.21	0.25	0.15	0.16
Short term debt to equity ratio	0.20	0.04	0.15	0.16
Current Ratio	1.74	10.93	0.78	4.07
Quick Ratio	1.01	--	--	3.90
Interest Coverage	-3.67	53.52	--	-14.83

Operating Efficiency Ratios

	Bon Natural Life (BON)	Theravance Biopharma (TBPH)	Aptorum Group Limited Class A - ADR	Universe Pharmaceuticals Inc (UPC)
Debtors to sales (%)	61.81	88.90	--	73.84
Asset Turnover	0.25	0.26	0.00	0.26
Receivable days	228.44	278.67	--	266.82
Inventory Days	257.00	-4,537.51	--	62.10
Payable days	136.67	159.28	--	104.04
Cash Conversion Cycle	348.77	-4,418.12	--	224.88

Annual
Quarterly